Becton Dickinson & Co (NYSE:BDX)
$ 235.67 0.67 (0.29%) Market Cap: 68.11 Bil Enterprise Value: 82.95 Bil PE Ratio: 51.91 PB Ratio: 2.65 GF Score: 81/100

Becton Dickinson and Co at Barclays Global Healthcare Conference Transcript

Mar 12, 2019 / 06:05PM GMT
Release Date Price: $244.3 (+0.26%)
Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

Thanks very much for joining us here. I'm Kristen Stewart, medical supplies and device analyst at Barclays. It's my pleasure to have Becton, Dickinson here for the session. Tom Polen, the President and COO of the company; as well as Chuck Bodner, the SVP of Corporate Finance, Chief Accounting Officer and Chief Financial Officer of International.

So just going to kick it off with a question for the audience on what you view to be Becton, Dickinson's sustainable organic growth rate for the next 3 years. You see the choices in front of you. You've got your devices, press your button. I'll do the countdown now.

(Voting)

Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

Let's see, Tom. Are you nervous?

Thomas E. Polen;Kristen Marie Stewart
Becton, Dickinson and Company - President & COO;Barclays Bank PLC,

Look forward to that. No. I'll tell you my answer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot